TribLIVE

| Business


 
Larger text Larger text Smaller text Smaller text | Order Photo Reprints

Complexa raises $13M to fund trials of kidney disease drug

Email Newsletters

Click here to sign up for one of our email newsletters.

On the Grid

From the shale fields to the cooling towers, Trib Total Media covers the energy industry in Western Pennsylvania and beyond. For the latest news and views on gas, coal, electricity and more, check out On the Grid today.

Daily Photo Galleries

Wednesday, June 4, 2014, 10:51 a.m.
 

Complexa Inc., a South Side-based drug development company, said it raised $13 million from investors that will fund clinical trials of a drug to treat kidney disease.

The funding round, Complexa's second, was led by Jafco Life Science Investment, an arm of Japanese private equity firm Jafco Co. Ltd.

The company previously raised more than $8 million from venture capital investors to license and develop molecules discovered and patented by professor Bruce Freeman and a team of researchers at the University of Pittsburgh.

There is “great interest” in Complexa's work from large pharmaceutical companies, Jafco officials said in a statement.

Add Alex Nixon to your Google+ circles.

Subscribe today! Click here for our subscription offers.

 

 

 


Show commenting policy

Most-Read Business Headlines

  1. Financial planning for disabled people a little-tapped field
  2. Murray, Alpha notify West Virginia coal miners of layoffs
  3. AT&T evolves beyond phones
  4. Stocks end quiet week with loss
  5. Consumer prices rose in April for 3rd straight month
  6. This robot is cute, artificially intelligent and employed
  7. American Eagle posts improved first-quarter results
  8. Developer hopes to make Allegheny Center a tech hub
  9. Shareholder vote causes ATI to review executive pay packages
  10. Home sales slipped in April on tight supply, high prices
  11. Taxes matter in  fund investing, even when there’s no bill